NEW YORK and BERLIN, Nov. 10, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today reported financial results for the quarter ended September 30, 2022 and provided a business update.
The post atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update appeared first on atai Life Sciences.
